Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response
Cells · 2023
DOI: 10.3390/cells12010180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Yang Su und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Carcinoma, Kidney Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Medical University Basic and Clinical Cooperative Research Promotion Project, National Level Innovation Training Program for Chinese College Students of the Ministry of Education of the People’s Republic of China, Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province.
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC) has a high metastatic rate, and its incidence and mortality are still rising. The aim of this study was to identify the key tumor-infiltrating immune cells (TIICs) affecting the distant metastasis and prognosis of patients with ccRCC and to construct a relevant prognostic panel to predict immunotherapy response. Based on ccRCC bulk RNA sequencing data, resting mast cells (RMCs) were screened and verified using the CIBERSORT algorithm, survival analysis, and expression analysis. Distant metastasis-associated genes were identified using single-cell RNA sequencing data. Subsequently, a three-gene (CFB, PPP1R18, and TOM1L1) panel with superior distant metastatic and prognostic performance was established and validated, which stratified patients into high- and low-risk groups. The high-risk group exhibited lower infiltration of RMCs, higher tumor mutation burden (TMB), and worse prognosis. Therapeutically, the high-risk group was more sensitive to anti-PD-1 and anti-CTLA-4 immunotherapy, whereas the low-risk group displayed a better response to anti-PD-L1 immunotherapy. Furthermore, two immune clusters revealing distinct immune, clinical, and prognosis heterogeneity were distinguished. Immunohistochemistry of ccRCC samples verified the expression patterns of the three key genes. Collectively, the prognostic panel based on RMCs is able to predict distant metastasis and immunotherapy response in patients with ccRCC, providing new insight for the treatment of advanced ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China.
- Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230031, China.
- The Institute of Urology, Anhui Medical University, Hefei 230031, China.
- Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China.
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China.
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7LD, UK.
ORCID-Profile: Tianxiang Zhang, Jinsen Lu
Förderung
- Anhui Medical University Basic and Clinical Cooperative Research Promotion Project
- National Level Innovation Training Program for Chinese College Students of the Ministry of Education of the People’s Republic of China
- Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province
Zitieren
APA
Su, Y., Zhang, T., Lu, J., Qian, L., Fei, Y., Zhang, L., Fan, S., Zhou, J., Tang, J., Chen, H., & Liang, C. (2023). Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. Cells. https://doi.org/10.3390/cells12010180
Vancouver
Su Y, Zhang T, Lu J, Qian L, Fei Y, Zhang L, et al. Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. Cells. 2023. doi:10.3390/cells12010180
BibTeX
@article{Su2023,
author = {Su, Yang and Zhang, Tianxiang and Lu, Jinsen and Qian, Lei and Fei, Yang and Zhang, Li and Fan, Song and Zhou, Jun and Tang, Jieqiong and Chen, Haige and Liang, Chaozhao},
title = {Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12010180}
}
EUVIMED